Batch Production Record and Device History Record Review and Quality Assessment to ensure compliance with DMF and DMR specifications


Jerry Dalfors is Keynote Speaker at Compliance key Inc.He has extensive (40+ years) of business administration, consultative, technical and managerial experience in the development and manufacture of highly regulated biopharmaceutical products including injectables, biologics, medical devices and oral dosages. He has held permanent employee, temporary employee and company representative management positions with a multitude of the major pharmaceutical and biotechnology companies in the US. He has worked with or assisted more than two dozen companies with the establishment of controlled documen........

Overview

Written procedures are to be established and followed for a time efficient and clear evidence of the quality related elements during the review and approval for release, including packaging and labeling, to determine compliance of the intermediates (FDA definition) and/or finished product with established specifications before a batch can be released for distribution
BPRs, DHRs and laboratory control records for critical process steps are to be reviewed and approved by the quality unit(s) before a finished product batch is released for distribution. Production and laboratory control records for earlier, non-critical process steps may be reviewed by qualified production personnel or other units following procedures approved by the quality unit(s).
All incidents or deviations, investigation, and OOS, OOT, OOL reports should be reviewed to ensure there is no product quality impact by providing technically written sound scientific rationale for the assessment and conclusion as part of the batch record review before the batch is released.

Why should you attend this webinar?

A vast majority of the current industry deficiencies which have led to isolated 483s, Warning Letters and Consent Decrees are the result of deficient technical documentation of the production processes for both injectables, devices and solid dosages.

Quality Systems require both Operations and Quality Departments to be unified with the overall intent of minimizing patient risk by documenting the process in a fashion that is technically accurate and easy to demonstrate that we are thinking and operating with the same objectives as the regulatory agencies are required to enforce.

Areas Covered in the Session:

Who can Benefit:

Quality and Documentation Personnel within the industry
Pharmaceutical, Medical Device and Solid Dosage as well as FDA, ISO, PDA, ISPE
Quality, Operations , Development Quality and Documentation Personnel within the industry.



Webinar Id: LSHCJB002

Training Options:

Duration: 60 mins

 View anytime

 Recorded: [Six month unlimited access]

 $167 (Single Attendee)  $599 (Unlimited Attendee)

Refund Policy
Past Webinar of Jerry Dalfors
LYOPHILIZATION TECHNOLOGY
Presenter: Jerry Dalfors
View it anytime
Price: $167
Batch Production Record and De....
Presenter: Jerry Dalfors
View it anytime
Price: $167

More Webinar

Upcoming Webinar: Life Sciences and Healthcare
HIPAA - Emailing, Texting, and....
Presenter: Brian L Tuttle
When: 07/26/2018 | 10:00 AM PT |01:00 PM ET
Price: $179
Understanding the HIPAA Compli....
Presenter: Jay Hodes
When: 07/30/2018 | 10:00 AM PT |01:00 PM ET
Price: $179

More Webinar

Past Webinar: Life Sciences and Healthcare
HIPAA Security Fundamentals
Presenter: Brian Freedman
View it anytime
Price: $167
Compliance with the 60-Day Ove....
Presenter: Jay Anstine
View it anytime
Price: $167

More Webinar

PayPal logo   PayPal Verified logo   godaddy logo
Copyright © 2018 Compliance Key. All Rights Reserved. Back to Top